Explore our library to discover product announcements, industry insights, company news and upcoming events. And subscribe to our newsletter to stay up to date.
From sensors, satellites, radar, video cameras, smartphones and other IoT devices, we collect over one trillion events each day, giving us one of the largest repositories of real-time Big Data in the world.
TransVoyant, the world’s only global intelligent supply chain execution platform, announced it has closed its first strategic growth equity financing co-led by Merck Global Health Innovation Fund (MGHIF) and P74 Ventures, bringing the company’s total funding to more than $30 million.
This customer success story illustrates how to enhance global end-to-end supply chain transparency and live situational awareness to proactively save shipments and improve customer service.
Learn how to proactively see, understand and continuously improve global supply chain transparency and situational awareness to save shipments, improve customer service and avoid unnecessary operational spending.
Chase Mueller, Manager, Supply Chain Visibility at Brooks Running, details how Brooks is using real-time big data and predictive analytics to dynamically manage availability date, drive efficiencies in downstream operations, reduce lead time, and improve customer service.
This on-demand webinar demystifies the use of big data analytics for supply chain management. And, via TransVoyant’s analytics integration with JDA’s Intelligent Fulfillment solution, it has never been easier to get up and running to put these predictive insights to work for your team.
TransVoyant, the first and only provider of global, intelligent supply chain orchestration, announced today it has hired two executives to new positions on its leadership team. Allison Fowler is the firm’s first Chief Product Officer and Charles Virden is the first Senior Vice President of Customer Growth.
TransVoyant, the world’s only global intelligent supply chain execution platform, announced it has closed its first strategic growth equity financing co-led by Merck Global Health Innovation Fund (MGHIF) and P74 Ventures, bringing the company’s total funding to more than $30 million.
Know what you don’t know.
TransVoyant empowers people who keep the world’s resources in motion to make informed decisions so production rolls smoothly and delivery promises get met – all while curbing costs, multiplying margins and respecting regulations.